Tremont, ME, United States of America

Peter Alexander Williams


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Peter Alexander Williams

Introduction

Peter Alexander Williams is a notable inventor based in Tremont, ME (US). He has made significant contributions to the field of neurodegenerative disorders, particularly in ocular health. With a total of 3 patents, his work focuses on innovative treatments that aim to improve the quality of life for individuals affected by these conditions.

Latest Patents

One of his latest patents involves the treatment and prevention of ocular neurodegenerative disorders. This invention relates to the use of a pharmaceutical composition containing nicotinamide (NAM) and/or pyruvate as a neuroprotective medicament or gene therapy. It specifically addresses axon degeneration of neuronal tissue in ocular-related neurodegeneration diseases, including glaucoma. This groundbreaking approach has the potential to revolutionize how these disorders are treated.

Career Highlights

Peter Williams is currently associated with The Jackson Laboratory, where he continues to advance his research and innovations. His work at this esteemed institution allows him to collaborate with other leading scientists and contribute to the understanding of neurodegenerative diseases.

Collaborations

One of his notable collaborators is Simon W M John, with whom he has worked on various projects related to ocular health and neurodegeneration. Their combined expertise enhances the potential for impactful discoveries in this critical area of research.

Conclusion

Peter Alexander Williams exemplifies the spirit of innovation in the field of neurodegenerative disorder treatment. His contributions through patents and collaborations are paving the way for new therapeutic options that could significantly benefit patients suffering from these debilitating conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…